The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall survival of patients with BRAF-mutant metastatic colorectal cancer treated with encorafenib-cetuximab in a real-world nationwide study in the Netherlands.
 
Sietske C.M.W. van Nassau
Research Funding - Pierre Fabre (Inst)
Travel, Accommodations, Expenses - SERVIER (Inst)
 
Koen Zwart
Research Funding - Bristol-Myers Squibb (Inst)
 
Frederieke van der Baan
Research Funding - Bristol-Myers Squibb (Inst)
 
Miriam Koopman
Research Funding - Bayer (Inst); BMS GmbH & Co. KG (Inst); Merck Serono (Inst); Personal Genome Diagnostics (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst); Servier (Inst)
 
Anna J. van Gestel
No Relationships to Disclose
 
Petur Snaebjornsson
Consulting or Advisory Role - Bayer Germany (Inst); MEDtalks (Inst); MSD (Inst)
 
Geraldine R. Vink
Consulting or Advisory Role - Merck (Inst)
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Delphi Diagnostics (Inst); Merck (Inst); Personal Genome Diagnostics (Inst); Sirtex Medical (Inst)
 
Jeanine Roodhart
Consulting or Advisory Role - Bayer (Inst); Bristol-Myers Squibb (Inst); Merck Serono (Inst); Pierre Fabre (Inst)
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); HUB Organoids (Inst); Merck Serono (Inst); Pierre Fabre (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - SERVIER (Inst)